A number of states in the United States are on course to adding female orgasmic disorder to a list of conditions that qualify for medical cannabis. Supporters have cited various studies that have demonstrated how marijuana can significantly improve orgasmic ease, satisfaction and frequency in individuals with female orgasmic disorder.
Female orgasmic disorder is characterized by a delay in or lack of sexual climax despite sexual arousal and sufficient sexual stimulation.
Among the states working on this initiative is Ohio, whose medical board announced that female orgasmic disorder and autism spectrum disorder would be forwarded for review and public commentary after petitions were submitted online. The state of Connecticut is also looking into adding the disorder to its list of qualifying conditions.
In Illinois, regulators have set a meeting for later this month where discussions on whether to add female orgasmic disorder to their qualifying conditions will take place. The Female Orgasm Research Institute also believes that New Mexico will be meeting in May to discuss the same.
The executive director and founder of the Female Orgasm Research Institute, Suzanne Mulvehill, is one of the leaders pushing for states to formally acknowledge the benefits marijuana can offer people with this disorder. Mulvehill, a clinical sexologist, stated that female orgasmic disorder affects more than 40% of women globally. She cited studies dating back decades but supported by recent research, which showed that cannabis consumption before sex could increase the likelihood of orgasm, boost satisfaction and ease difficulty in orgasming, among other benefits.
Mulvehill’s dissertation in clinical sexology also centered on the use of marijuana in managing female orgasmic disorder, with her findings showing that more than 50% of female subjects involved in the study suffered from the condition. In a recent interview, Mulvehill explained that women with the condition were also on more pharmaceutical drugs and had more mental health issues, including depression and anxiety. She noted that the inclusion wasn’t solely based on pleasure but the fact that it was a medical disorder that deserved treatment.
Awareness that marijuana may help women achieve orgasms isn’t new among marijuana users. Current studies show that almost one-third of women who use marijuana do so to improve sexual satisfaction.
There’s also increasing evidence that cannabis can improve sexual function, regardless of gender or sex. One 2023 study discovered that more than 70% of adults who used marijuana before sex noticed improved orgasms and increased desire. Additionally, at least 62% of participants felt marijuana enhanced pleasure during masturbation.
Marijuana companies such as TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) may keep a close eye on the trend of adding FOD to qualifying conditions’ lists because it could open opportunities for developing customized products targeting females with this condition.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN